基本信息
views: 8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Quinn is known for his research on retinopathy of prematurity, assessment of visual function and ocular development, and vision screening and treatment of amblyopia in young children. He has helped develop techniques to assess disease or treatment modalities in infants and children who are at risk for developing severe retinopathy of prematurity. An active area of his research revolves around telemedicine and the digital imaging of the neonate ocular fundus while in the neonatal intensive care unit. Dr. Quinn leads a large NEI-funded study of remote evaluation of digital images from premature infants that has resulted in several recent publications.
In addition, Dr Quinn is a sought-after participant in international collaborations for the prevention of blindness from retinopathy of prematurity.
In addition, Dr Quinn is a sought-after participant in international collaborations for the prevention of blindness from retinopathy of prematurity.
Research Interests
Papers共 327 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITIONpp.fetalneonatal-2024, (2024)
Springer eBookspp.169-183, (2023)
Cited0Views0Bibtex
0
0
JAMA ophthalmology (2023)
JOURNAL OF AAPOSno. 6 (2022): 307.e1-307.e5
Journal of American Association for Pediatric Ophthalmology and Strabismusno. 4 (2022): e3-e3
Robert A Avery, Cammille Go,Michael J Fisher,Grant T Liu,Arielle Garcia, Meg Richter,Brendan McGeehan,Graham E Quinn,Gui-Shuang Ying
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn